4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-22-060587
General Counsel sold 1,048 shares at $4.95 ($5,185)
- General Counsel acquired 2,554 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Walker Marlan D · General Counsel
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 1 in the form | +1,010 | 6,189 | D | ||
| 2022-12-06 | Exercise or conversion : show line 2 in the form | +1,156 | 7,345 | D | ||
| 2022-12-06 | Exercise or conversion : show line 3 in the form | +388 | 7,733 | D | ||
| 2022-12-06 | Sale : show line 4 in the form | −1,048 | $4.95 | $5,185 | 6,685 | D |
| Open-market sales · 1,048 sh · avg $4.95 · $5,185 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −1,010 | 1,010 | D |
| 2022-12-06 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −1,156 | 2,311 | D |
| 2022-12-06 | Exercise or conversion : show line 7 in the form Restricted Stock Unit | −388 | 770 | D |
Loading xslF345X03/doc4.xml…